HUYA Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 18, 2025

2025-02-26 IDOPRESS

-Earnings Webinar Scheduled for 6:00 a.m. ET on March 18,2025-

GUANGZHOU,China,Feb. 25,2025 --HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA),a leading game live streaming platform in China,today announced that it will report its fourth quarter and fiscal year 2024 unaudited financial results on Tuesday,March 18,2025,before the open of U.S. markets.

The Company'smanagement will host a Tencent Meeting Webinar at 6:00 a.m. U.S. Eastern Time on March 18,2025 (6:00 p.m. Beijing/Hong Kong time on March 18,2025),to review and discuss the Company's business and financial performance.

For participants who wish to join the webinar,please complete the online registration in advance using the links provided below. Upon registration,participants will receive an email with webinar access information,including meeting ID,meeting link,dial-in numbers,and a unique attendee ID to join the webinar.

Participant Online Registration

Chinese Mainland[1]:

https://meeting.tencent.com/dw/Oi4kDZin2ViT


International:

https://voovmeeting.com/dw/Oi4kDZin2ViT


A live webcast of the webinar will be accessible at https://ir.huya.com,and a replay of the webcast will be available following the session.

[1]For the purpose of this announcement only,Chinese Mainland excludes the Hong Kong Special Administrative Region,the Macao Special Administrative Region of the People's Republic of China,and Taiwan.

About HUYA Inc.

HUYA Inc. is a leading game live streaming platform in China. As a technology-driven company,Huya offers rich and dynamic content across games,e-sports,and other entertainment genres where it has cultivated a large,highly engaged,interactive,immersive community of game enthusiasts. Building on its success in game live streaming and through close collaboration with game companies,e-sports tournament organizers,broadcasters and talent agencies,Huya is expanding its presence in the game industry,both domestically and internationally. By providing more innovative game-related services,the Company is committed to meeting the evolving needs of game enthusiasts,content creators,and industry partners.

For more information,please visit: https://ir.huya.com.

For investor and media inquiries,please contact:

In China:

HUYA Inc.


Investor Relations


Tel: +86-20-2290-7829


E-mail:ir@huya.com

Piacente Financial Communications


Jenny Cai


Tel: +86-10-6508-0677


E-mail: huya@tpg-ir.com

In the United States:

Piacente Financial Communications


Brandi Piacente


Tel: +1-212-481-2050


E-mail: huya@tpg-ir.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map